Zhenghai Biological Disclosure achieved revenue of 231 million yuan in the semi -annual report of 2022
Author:Capital state Time:2022.08.19
On August 18, A -share listed company Zhenghai Biological (Code: 300653.SZ) released the semi -annual performance report in 2022.
From January 1, 2022-June 30, 2022, the company realized operating income of 231 million yuan, an increase of 15.15%year-on-year, and net profit was 104 million yuan, an increase of 28.36%year-on-year, and the basic earnings per share were 0.58 yuan.
The company's industry is a medical device.
During the company's reporting period, the total assets at the end of the period were 926 million yuan, the operating profit was 121 million yuan, the accounts receivable were 48.166 million yuan, and the net cash flow generated by operating activities was 109 million yuan.Cash is 227 million yuan.
Zhenghai Biological, the company's full name Yantai Zhenghai Biotechnology Co., Ltd., was established on October 22, 2003. The current general manager Sha Shizhuang, the main business is the research and development, production and sales of biological regeneration materials.
- END -
Cambrian: The losses in the first half of 2022 expanded to 622 million yuan year -on -year
On August 12, 2022, the A -share listed company Cambrian (code: 688256.SH) released the 2022 semi -annual performance report.From January 1, 2022-June 30, 2022, the company realized operating income o
Zhongqingbao was exposed to the game version number transaction: the asking price of 400,000 yuan, but it cannot guarantee the normal use of the version number, or is suspected of violating the law
On July 12, the website of the National Press and Publication Agency announced the...